Ghrelin is a physiological regulator of insulin release in pancreatic islets and glucose homeostasis

Pharmacology and Therapeutics

Volumn 118, Issue 2, 2008, Pages 239-249

  Dezaki, Katsuya ^a   Sone, Hedeyuki ^a   Yada, Toshihiko ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Cytosolic Ca2+ concentrations; Ghrelin; Glucose homeostasis; Growth hormone secretagogue receptor; Insulin release; Obesity; Pancreatic islets; Type 2 diabetes; Voltage dependent K+ channels

Indexed keywords

CALCIUM ION; GHRELIN; GLUCOSE; GROWTH HORMONE; GUANINE NUCLEOTIDE BINDING PROTEIN; INSULIN; OBESTATIN; PEPTIDE; PERTUSSIS TOXIN;

CELL ISOLATION; DOWN REGULATION; ELECTRIC ACTIVITY; GASTRECTOMY; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; GROWTH HORMONE RELEASE; HORMONE ACTION; HORMONE INHIBITION; HORMONE RELEASE; HUMAN; INSULIN BLOOD LEVEL; INSULIN RELEASE; KNOCKOUT MOUSE; LIPID DIET; MICROCIRCULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PANCREAS ISLET; PANCREAS ISLET BETA CELL; POTASSIUM CURRENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; DIABETES MELLITUS, TYPE 2; GHRELIN; GLUCOSE; HOMEOSTASIS; HUMANS; INSULIN; ISLETS OF LANGERHANS; MICE; MICE, KNOCKOUT; PERTUSSIS TOXIN; SIGNAL TRANSDUCTION;

EID: 43049170316     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2008.02.008     Document Type: Review

References (148)

1. Aguilar-Bryan L., and Bryan J. Molecular biology of adenosine triphosphate-sensitive potassium channels. Endocr Rev 20 (1999) 101-135
2. Ahrén B. Autonomic regulation of islet hormone secretion - implications for health and disease. Diabetologia 43 (2000) 393-410
3. Ariyasu H., Takaya K., Hosoda H., Iwakura H., Ebihara K., Mori K., et al. Delayed short-term secretory regulation of ghrelin in obese animals: evidenced by a specific RIA for the active form of ghrelin. Endocrinology 143 (2002) 3341-3350
4. Ariyasu H., Takaya K., Tagami T., Ogawa Y., Hosoda K., Akamizu T., et al. Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans. J Clin Endocrinol Metab 86 (2001) 4753-4758
5. Arvat E., Di Vito L., Broglio F., Papotti M., Muccioli G., Dieguez C., et al. Preliminary evidence that Ghrelin, the natural GH secretagogue (GHS)-receptor ligand, strongly stimulates GH secretion in humans. J Endocrinol Invest 23 (2000) 493-495
6. Arvat E., Maccario M., Di Vito L., Broglio F., Benso A., Gottero C., et al. Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone. J Clin Endocrinol Metab 86 (2001) 1169-1174
7. Asakawa A., Inui A., Kaga T., Katsuura G., Fujimiya M., Fujino M.A., et al. Antagonism of ghrelin receptor reduces food intake and body weight gain in mice. Gut 52 (2003) 947-952
8. 11 α-subunits in rat pancreatic endocrine cells. J Histochem Cytochem 47 (1999) 289-302
9. Bednarek M.A., Feighner S.D., Pong S.S., McKee K.K., Hreniuk D.L., Silva M.V., et al. Structure-function studies on the new growth hormone-releasing peptide, ghrelin: minimal sequence of ghrelin necessary for activation of growth hormone secretagogue receptor 1a. J Med Chem 43 (2000) 4370-4376
10. Bresson-Bepoldin L., and Dufy-Barbe L. GHRP6-stimulated hormone secretion in somatotrophs: involvement of intracellular and extracellular calcium sources. J Neuroendocrinol 8 (1996) 309-314
11. Briscoe C.P., Tadayyon M., Andrews J.L., Benson W.G., Chambers J.K., Eilert M.M., et al. The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids. J Biol Chem 278 (2003) 11303-11311
12. Broglio F., Arvat E., Benso A., Gottero C., Muccioli G., Papotti M., et al. Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans. J Clin Endocrinol Metab 86 (2001) 5083-5086
13. Broglio F., Arvat E., Benso A., Gottero C., Prodam F., Grottoli S., et al. Endocrine activities of cortistatin-14 and its interaction with GHRH and ghrelin in humans. J Clin Endocrinol Metab 87 (2002) 3783-3790
14. Broglio F., Benso A., Castiglioni C., Gottero C., Prodam F., Destefanis S., et al. The endocrine response to ghrelin as a function of gender in humans in young and elderly subjects. J Clin Endocrinol Metab 88 (2003) 1537-1542
15. Broglio F., Benso A., Gottero C., Prodam F., Gauna C., Filtri L., et al. Non-acylated ghrelin does not possess the pituitaric and pancreatic endocrine activity of acylated ghrelin in humans. J Endocrinol Invest 26 (2003) 192-196
16. Broglio F., Gottero C., Prodam F., Gauna C., Muccioli G., Papotti M., et al. Non-acylated ghrelin counteracts the metabolic but not the neuroendocrine response to acylated ghrelin in humans. J Clin Endocrinol Metab 89 (2004) 3062-3065
17. Cassoni P., Papotti M., Ghè C., Catapano F., Sapino A., Graziani A., et al. Identification, characterization, and biological activity of specific receptors for natural (ghrelin) and synthetic growth hormone secretagogues and analogs in human breast carcinomas and cell lines. J Clin Endocrinol Metab 86 (2001) 1738-1745
18. Chan C.B., De Leo D., Joseph J.W., McQuaid T.S., Ha X.F., Xu F., et al. Increased uncoupling protein-2 levels in β-cells are associated with impaired glucose-stimulated insulin secretion: mechanism of action. Diabetes 50 (2001) 1302-1310
19. Chan C.B., MacDonald P.E., Saleh M.C., Johns D.C., Marban E., and Wheeler M.B. Overexpression of uncoupling protein 2 inhibits glucose-stimulated insulin secretion from rat islets. Diabetes 48 (1999) 1482-1486
20. Chanoine J.P., and Wong A.C. Ghrelin gene expression is markedly higher in fetal pancreas compared with fetal stomach: effect of maternal fasting. Endocrinology 145 (2004) 3813-3820
21. Chanoine J.P., Wong A.C., and Barrios V. Obestatin, acylated and total ghrelin concentrations in the perinatal rat pancreas. Horm Res 66 (2006) 81-88
22. Chiang M.K., and Flanagan J.G. PTP-NP, a new member of the receptor protein tyrosine phosphatase family, implicated in development of nervous system and pancreatic endocrine cells. Development 122 (1996) 2239-2250
23. Colombo M., Gregersen S., Xiao J., and Hermansen K. Effects of ghrelin and other neuropeptides (CART, MCH, orexin A and B, and GLP-1) on the release of insulin from isolated rat islets. Pancreas 27 (2003) 161-166
24. Cui L., Yu W.P., DeAizpurua H.J., Schmidli R.S., and Pallen C.J. Cloning and characterization of islet cell antigen-related protein-tyrosine phosphatase (PTP), a novel receptor-like PTP and autoantigen in insulin-dependent diabetes. J Biol Chem 271 (1996) 24817-24823
25. Cummings D.E., and Foster K.E. Ghrelin-leptin tango in body-weight regulation. Gastroenterology 124 (2003) 1532-1535
26. Cummings D.E., Weigle D.S., Frayo R.S., Breen P.A., Ma M.K., Dellinger E.P., et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med 346 (2002) 1623-1630
27. Cummings D.E., and Overduin J. Gastrointestinal regulation of food intake. J Clin Invest 117 (2007) 13-23
28. Date Y., Kojima M., Hosoda H., Sawaguchi A., Mondal M.S., Suganuma T., et al. Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology 141 (2000) 4255-4261
29. Date Y., Murakami N., Kojima M., Kuroiwa T., Matsukura S., Kangawa K., et al. Central effects of a novel acylated peptide, ghrelin, on growth hormone release in rats. Biochem Biophys Res Commun 275 (2000) 477-480
30. Date Y., Nakazato M., Hashiguchi S., Dezaki K., Mondal M.S., Hosoda H., et al. Ghrelin is present in pancreatic α-cells of humans and rats and stimulates insulin secretion. Diabetes 51 (2002) 124-129
31. De Smet B., Depoortere I., Moechars D., Swennen Q., Moreaux B., Cryns K., et al. Energy homeostasis and gastric emptying in ghrelin knockout mice. J Pharmacol Exp Ther 316 (2006) 431-439
32. 2+ signaling in β-cells: implication in the glycemic control in rodents. Diabetes 53 (2004) 3142-3151
33. 2+ signaling and insulin release in islet β-cells: novel signal transduction of ghrelin. Diabetes 56 (2007) 2319-2327
34. Dezaki K., Sone H., Koizumi M., Nakata M., Kakei M., Nagai H., et al. Blockade of pancreatic islet-derived ghrelin enhances insulin secretion to prevent high-fat diet-induced glucose intolerance. Diabetes 55 (2006) 3486-3493
35. Doi A., Shono T., Nishi M., Furuta H., Sasaki H., and Nanjo K. IA-2β, but not IA-2, is induced by ghrelin and inhibits glucose-stimulated insulin secretion. Proc Natl Acad Sci U S A 103 (2006) 885-890
36. Drake P.G., Peters G.H., Andersen H.S., Hendriks W., and Møller N.P. A novel strategy for the development of selective active-site inhibitors of the protein tyrosine phosphatase-like proteins islet-cell antigen 512 (IA-2) and phogrin (IA-2β). Biochem J 373 (2003) 393-401
37. Egido E.M., Rodriguez-Gallardo J., Silvestre R.A., and Marco J. Inhibitory effect of ghrelin on insulin and pancreatic somatostatin secretion. Eur J Endocrinol 146 (2002) 241-244
38. Escoubas P., Diochot S., Celerier M.L., Nakajima T., and Lazdunski M. Novel tarantula toxins for subtypes of voltage-dependent potassium channels in the Kv2 and Kv4 subfamilies. Mol Pharmacol 62 (2002) 48-57
39. Esler W.P., Rudolph J., Claus T.H., Tang W., Barucci N., Brown S.E., et al. Small-molecule ghrelin receptor antagonists improve glucose tolerance, suppress appetite, and promote weight loss. Endocrinology 148 (2007) 5175-5185
40. 2+ channel and link to insulin release. Am J Physiol 289 (2005) E670-E677
41. Gauna C., Delhanty P.J., Hofland L.J., Janssen J.A., Broglio F., Ross R.J., et al. Ghrelin stimulates, whereas des-octanoyl ghrelin inhibits, glucose output by primary hepatocytes. J Clin Endocrinol Metab 90 (2005) 1055-1060
42. Gautam D., Han S.J., Hamdan F.F., Jeon J., Li B., Li J.H., et al. A critical role for β cell M3 muscarinic acetylcholine receptors in regulating insulin release and blood glucose homeostasis in vivo. Cell Metab 3 (2006) 449-461
43. Ghigo E., Arvat E., Giordano R., Broglio F., Gianotti L., Maccario M., et al. Biologic activities of growth hormone secretagogues in humans. Endocrine 14 (2001) 87-93
44. Gilon P., and Henquin J.C. Mechanisms and physiological significance of the cholinergic control of pancreatic β-cell function. Endocr Rev 22 (2001) 565-604
45. Glavaski-Joksimovic A., Jeftinija K., Jeremic A., Anderson L.L., and Jeftinija S. Mechanism of action of growth hormone secretagogue, L-692,585, on cultured porcine somatotropes. J Endocrinol 175 (2002) 625-636
46. Glavaski-Joksimovic A., Jeftinija K., Scanes C.G., Anderson L.L., and Jeftinija S. Stimulatory effect of ghrelin on isolated porcine somatotropes. Neuroendocrinology 77 (2003) 366-378
47. Gnanapavan S., Kola B., Bustin S.A., Morris D.G., McGee P., Fairclough P., et al. The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J Clin Endocrinol Metab 87 (2002) 2988-2991
48. Granata R., Settanni F., Biancone L., Trovato L., Nano R., Bertuzzi F., et al. Acylated and unacylated ghrelin promote proliferation and inhibit apoptosis of pancreatic β-cells and human islets: involvement of 3′,5′-cyclic adenosine monophosphate/protein kinase A, extracellular signal-regulated kinase 1/2, and phosphatidyl inositol 3-Kinase/Akt signaling. Endocrinology 148 (2007) 512-529
49. Green B.D., Irwin N., and Flatt P.R. Direct and indirect effects of obestatin peptides on food intake and the regulation of glucose homeostasis and insulin secretion in mice. Peptides 28 (2007) 981-987
50. Grodsky G.M., and Fanska R.E. The in vitro perfused pancreas. Methods Enzymol 39 (1975) 364-372
51. Gualillo O., Caminos J., Blanco M., Garcia-Caballero T., Kojima M., Kangawa K., et al. Ghrelin, a novel placental-derived hormone. Endocrinology 142 (2001) 788-794
52. Guan X.M., Yu H., Palyha O.C., McKee K.K., Feighner S.D., Sirinathsinghji D.J., et al. Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues. Mol Brain Res 48 (1997) 23-29
53. Hattori N., Saito T., Yagyu T., Jiang B.H., Kitagawa K., and Inagaki C. GH, GH receptor, GH secretagogue receptor, and ghrelin expression in human T cells, B cells, and neutrophils. J Clin Endocrinol Metab 86 (2001) 4284-4291
54. Heijboer A.C., van den Hoek A.M., Parlevliet E.T., Havekes L.M., Romijn J.A., Pijl H., et al. Ghrelin differentially affects hepatic and peripheral insulin sensitivity in mice. Diabetologia 49 (2006) 732-738
55. Heller R.S., Jenny M., Collombat P., Mansouri A., Tomasetto C., Madsen O.D., et al. Genetic determinants of pancreatic ε-cell development. Dev Biol 286 (2005) 217-224
56. Herrington J., and Hille B. Growth hormone-releasing hexapeptide elevates intracellular calcium in rat somatotropes by two mechanisms. Endocrinology 135 (1994) 1100-1108
57. Herrington J., Zhou Y.P., Bugianesi R.M., Dulski P.M., Feng Y., Warren V.A., et al. Blockers of the delayed-rectifier potassium current in pancreatic β-cells enhance glucose-dependent insulin secretion. Diabetes 55 (2006) 1034-1042
58. Holst B., Cygankiewicz A., Jensen T.H., Ankersen M., and Schwartz T.W. High constitutive signaling of the ghrelin receptor - identification of a potent inverse agonist. Mol Endocrinol 17 (2003) 2201-2210
59. Holst B., Egerod K.L., Schild E., Vickers S.P., Cheetham S., Gerlach L.O., et al. GPR39 signaling is stimulated by zinc ions but not by obestatin. Endocrinology 148 (2007) 13-20
60. Holst B., Holliday N.D., Bach A., Elling C.E., Cox H.M., and Schwartz T.W. Common structural basis for constitutive activity of the ghrelin receptor family. J Biol Chem 279 (2004) 53806-53817
61. Hong Y., Fink B.D., Dillon J.S., and Sivitz W.I. Effects of adenoviral overexpression of uncoupling protein-2 and -3 on mitochondrial respiration in insulinoma cells. Endocrinology 142 (2001) 249-256
62. Hosoda H., Kojima M., Matsuo H., and Kangawa K. Ghrelin and des-acyl ghrelin: two major forms of rat ghrelin peptide in gastrointestinal tissue. Biochem Biophys Res Commun 279 (2000) 909-913
63. Howard A.D., Feighner S.D., Cully D.F., Arena J.P., Liberator P.A., Rosenblum C.I., et al. A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 273 (1996) 974-977
64. 2+ channels in the beta cell. J Biol Chem 266 (1991) 837-843
65. Ikezaki A., Hosoda H., Ito K., Iwama S., Miura N., Matsuoka H., et al. Fasting plasma ghrelin levels are negatively correlated with insulin resistance and PAI-1, but not with leptin, in obese children and adolescents. Diabetes 51 (2002) 3408-3411
66. Itoh Y., Kawamata Y., Harada M., Kobayashi M., Fujii R., Fukusumi S., et al. Free fatty acids regulate insulin secretion from pancreatic β cells through GPR40. Nature 422 (2003) 173-176
67. Iwakura H., Hosoda K., Son C., Fujikura J., Tomita T., Noguchi M., et al. Analysis of rat insulin II promoter-ghrelin transgenic mice and rat glucagon promoter-ghrelin transgenic mice. J Biol Chem 280 (2005) 15247-15256
68. Jeffery P.L., Duncan R.P., Yeh A.H., Jaskolski R.A., Hammond D.S., Herington A.C., et al. Expression of the ghrelin axis in the mouse: an exon 4-deleted mouse proghrelin variant encodes a novel C terminal peptide. Endocrinology 146 (2005) 432-440
69. Joseph J.W., Koshkin V., Zhang C.Y., Wang J., Lowell B.B., Chan C.B., et al. Uncoupling protein 2 knockout mice have enhanced insulin secretory capacity after a high-fat diet. Diabetes 51 (2002) 3211-3219
70. Kageyama H., Funahashi H., Hirayama M., Takenoya F., Kita T., Kato S., et al. Morphological analysis of ghrelin and its receptor distribution in the rat pancreas. Regul Pept 126 (2005) 67-71
71. Kamegai J., Tamura H., Shimizu T., Ishii S., Sugihara H., and Wakabayashi I. Chronic central infusion of ghrelin increases hypothalamic neuropeptide Y and Agouti-related protein mRNA levels and body weight in rats. Diabetes 50 (2001) 2438-2443
72. Katada T., and Ui M. Islet-activating protein. Enhanced insulin secretion and cyclic AMP accumulation in pancreatic islets due to activation of native calcium ionophores. J Biol Chem 254 (1979) 469-479
73. Katugampola S.D., Maguire J.J., Kuc R.E., Wiley K.E., and Davenport A.P. Discovery of recently adopted orphan receptors for apelin, urotensin II, and ghrelin identified using novel radioligands and functional role in the human cardiovascular system. Can J Physiol Pharmacol 80 (2002) 369-374
74. Keahey H.H., Boyd III A.E., and Kunze D.L. Catecholamine modulation of calcium currents in clonal pancreatic β-cells. Am J Physiol 257 (1989) C1171-C1176
75. 2+ signaling via protein kinase A and N-type channel-dependent mechanisms and cross-talk with leptin and orexin. Diabetes 52 (2003) 948-956
76. Kohno D., Nakata M., Maekawa F., Fujiwara K., Maejima Y., Kuramochi M., et al. Leptin suppresses ghrelin-induced activation of neuropeptide Y neurons in the arcuate nucleus via phosphatidylinositol 3-kinase- and phosphodiesterase 3-mediated pathway. Endocrinology 148 (2007) 2251-2263
77. Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., and Kangawa K. Ghrelin is a growth-hormone-releasing peptide from stomach. Nature 402 (1999) 656-660
78. Kojima M., Hosoda H., Matsuo H., and Kangawa K. Ghrelin: discovery of the natural endogenous ligand for the growth hormone secretagogue receptor. Trends Endocrinol Metab 12 (2001) 118-122
79. Kojima M., and Kangawa K. Drug insight: the functions of ghrelin and its potential as a multitherapeutic hormone. Nat Clin Prac Endocrinol Metab 2 (2006) 80-88
80. Lauwers E., Landuyt B., Arckens L., Schoofs L., and Luyten W. Obestatin does not activate orphan G protein-coupled receptor GPR39. Biochem Biophys Res Commun 351 (2006) 21-25
81. Lin Y., Matsumura K., Fukuhara M., Kagiyama S., Fujii K., and Iida M. Ghrelin acts at the nucleus of the solitary tract to decrease arterial pressure in rats. Hypertension 43 (2004) 977-982
82. Lu J., Li Q., Xie H., Chen Z.J., Borovitskaya A.E., Maclaren N.K., et al. Identification of a second transmembrane protein tyrosine phosphatase, IA-2β, as an autoantigen in insulin-dependent diabetes mellitus: precursor of the 37-kDa tryptic fragment. Proc Natl Acad Sci U S A 93 (1996) 2307-2311
83. + channel families regulate insulin secretion. Mol Endocrinol 15 (2001) 1423-1435
84. + channels in pancreatic β-cells enhances glucose-dependent insulin secretion. J Biol Chem 277 (2002) 44938-44945
85. + channels in pancreatic beta cells: role, regulation and potential as therapeutic targets. Diabetologia 46 (2003) 1046-1062
86. Magistrelli G., Toma S., and Isacchi A. Substitution of two variant residues in the protein tyrosine phosphatase-like PTP35/IA-2 sequence reconstitutes catalytic activity. Biochem Biophys Res Commun 227 (1996) 581-588
87. Malagon M.M., Luque R.M., Ruiz-Guerrero E., Rodriguez-Pacheco F., Garcia-Navarro S., Casanueva F.F., et al. Intracellular signaling mechanisms mediating ghrelin-stimulated growth hormone release in somatotropes. Endocrinology 144 (2003) 5372-5380
88. Matsumoto M., Hosoda H., Kitajima Y., Morozumi N., Minamitake Y., Tanaka S., et al. Structure-activity relationship of ghrelin: pharmacological study of ghrelin peptides. Biochem Biophys Res Commun 287 (2001) 142-146
89. Matsumura K., Tsuchihashi T., Fujii K., Abe I., and Iida M. Central ghrelin modulates sympathetic activity in conscious rabbits. Hypertension 40 (2002) 694-699
90. McDermott A.M., and Sharp G.W. Gi2 and Gi3 proteins mediate the inhibition of adenylyl cyclase by galanin in the RINm5F cell. Diabetes 44 (1995) 453-459
91. McKee K.K., Tan C.P., Palyha O.C., Liu J., Feighner S.D., Hreniuk D.L., et al. Cloning and characterization of two human G protein-coupled receptor genes (GPR38 and GPR39) related to the growth hormone secretagogue and neurotensin receptors. Genomics 46 (1997) 426-434
92. Moechars D., Depoortere I., Moreaux B., de Smet B., Goris I., Hoskens L., et al. Altered Gastrointestinal and metabolic function in the GPR39-obestatin receptor-knockout mouse. Gastroenterology 131 (2006) 1131-1141
93. Mori K., Yoshimoto A., Takaya K., Hosoda K., Ariyasu H., Yahata K., et al. Kidney produces a novel acylated peptide, ghrelin. FEBS Lett 486 (2000) 213-216
94. Muccioli G., Ghè C., Ghigo M.C., Papotti M., Arvat E., Boghen M.F., et al. Specific receptors for synthetic GH secretagogues in the human brain and pituitary gland. J Endocrinol 157 (1998) 99-106
95. Muccioli G., Pons N., Ghè C., Catapano F., Granata R., and Ghigo E. Ghrelin and des-acyl ghrelin both inhibit isoproterenol-induced lipolysis in rat adipocytes via a non-type 1a growth hormone secretagogue receptor. Eur J Pharmacol 498 (2004) 27-35
96. Muccioli G., Tschop M., Papotti M., Deghenghi R., Heiman M., and Ghigo E. Neuroendocrine and peripheral activities of ghrelin: implications in metabolism and obesity. Eur J Pharmacol 440 (2002) 235-254
97. Nagaya N., and Kangawa K. Ghrelin improves left ventricular dysfunction and cardiac cachexia in heart failure. Curr Opin Pharmacol 3 (2003) 146-151
98. Nagaya N., and Kangawa K. Ghrelin, a novel growth hormone releasing peptide, in the treatment of chronic heart failure. Regul Pept 114 (2003) 71-77
99. Nagaya N., Kojima M., Uematsu M., Yamagishi M., Hosoda H., Oya H., et al. Hemodynamic and hormonal effects of human ghrelin in healthy volunteers. Am J Physiol 280 (2001) R1483-R1487
100. Nagaya N., Miyatake K., Uematsu M., Oya H., Shimizu W., Hosoda H., et al. Hemodynamic, renal, and hormonal effects of ghrelin infusion in patients with chronic heart failure. J Clin Endocrinol Metab 86 (2001) 5854-5859
101. Nagaya N., Uematsu M., Kojima M., Ikeda Y., Yoshihara F., Shimizu W., et al. Chronic administration of ghrelin improves left ventricular dysfunction and attenuates development of cardiac cachexia in rats with heart failure. Circulation 104 (2001) 1430-1435
102. Nakazato M., Murakami N., Date Y., Kojima M., Matsuo H., Kangawa K., et al. A role for ghrelin in the central regulation of feeding. Nature 409 (2001) 194-198
103. Papotti M., Ghè C., Cassoni P., Catapano F., Deghenghi R., Ghigo E., et al. Growth hormone secretagogue binding sites in peripheral human tissues. J Clin Endocrinol Metab 85 (2000) 3803-3807
104. Parton L.E., Ye C.P., Coppari R., Enriori P.J., Choi B., Zhang C.Y., et al. Glucose sensing by POMC neurons regulates glucose homeostasis and is impaired in obesity. Nature 449 (2007) 228-232
105. Patel A.D., Stanley S.A., Murphy K.G., Frost G.S., Gardiner J.V., Kent A.S., et al. Ghrelin stimulates insulin-induced glucose uptake in adipocytes. Regul Pept 134 (2006) 17-22
106. Peino R., Baldelli R., Rodriguez-Garcia J., Rodriguez-Segade S., Kojima M., Kangawa K., et al. Ghrelin-induced growth hormone secretion in humans. Eur J Endocrinol 143 (2000) R11-R14
107. Portela-Gomes G.M., and Abdel-Halim S.M. Overexpression of Gs proteins and adenylyl cyclase in normal and diabetic islets. Pancreas 25 (2002) 176-181
108. Poykko S.M., Kellokoski E., Horkko S., Kauma H., Kesaniemi Y.A., and Ukkola O. Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes. Diabetes 52 (2003) 2546-2553
109. Prado C.L., Pugh-Bernard A.E., Elghazi L., Sosa-Pineda B., and Sussel L. Ghrelin cells replace insulin-producing β cells in two mouse models of pancreas development. Proc Natl Acad Sci U S A 101 (2004) 2924-2929
110. 2+, cAMP, and phospholipid-derived messengers in coupling mechanisms of insulin secretion. Physiol Rev 67 (1987) 1185-1248
111. Reimer M.K., Pacini G., and Ahrén B. Dose-dependent inhibition by ghrelin of insulin secretion in the mouse. Endocrinology 144 (2003) 916-921
112. i2 and investigations on the mechanism involved. Cell Biochem Funct 23 (2005) 205-212
113. Samols E., and Stagner J.I. Islet somatostatin - microvascular, paracrine, and pulsatile regulation. Metabolism 39 (1990) 55-60
114. oα in HIT-T15 cells. Diabetes 44 (1995) 85-89
115. Sharp G.W.G. Mechanisms of inhibition of insulin release. Am J Physiol 271 (1996) C1781-C1799
116. Shiau Y.S., Huang P.T., Liou H.H., Liaw Y.C., Shiau Y.Y., and Lou K.L. Structural basis of binding and inhibition of novel tarantula toxins in mammalian voltage-dependent potassium channels. Chem Res Toxicol 16 (2003) 1217-1225
117. Shiiya T., Nakazato M., Mizuta M., Date Y., Mondal M.S., Tanaka M., et al. Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. J Clin Endocrinol Metab 87 (2002) 240-244
118. Shintani M., Ogawa Y., Ebihara K., Aizawa-Abe M., Miyanaga F., Takaya K., et al. Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway. Diabetes 50 (2001) 227-232
119. Skoglund G., Basmaciogullari A., Rouot B., Marie J.C., and Rosselin G. Cell-specific localization of G protein α-subunits in the islets of Langerhans. J Endocrinol 162 (1999) 31-37
120. Smith P.D., Barker K.T., Wang J., Lu Y.J., Shipley J., and Crompton M.R. ICAAR, a novel member of a new family of transmembrane, tyrosine phosphatase-like proteins. Biochem Biophys Res Commun 229 (1996) 402-411
121. Smith R.G., Van der Ploeg L.H., Howard A.D., Feighner S.D., Cheng K., Hickey G.J., et al. Peptidomimetic regulation of growth hormone secretion. Endocr Rev 18 (1997) 621-645
122. Sun Y., Ahmed S., and Smith R.G. Deletion of ghrelin impairs neither growth nor appetite. Mol Cell Biol 23 (2003) 7973-7981
123. Sun Y., Asnicar M., Saha P.K., Chan L., and Smith R.G. Ablation of ghrelin improves the diabetic but not obese phenotype of ob/ob mice. Cell Metab 3 (2006) 379-386
124. Takaya K., Ariyasu H., Kanamoto N., Iwakura H., Yoshimoto A., Harada M., et al. Ghrelin strongly stimulates growth hormone release in humans. J Clin Endocrinol Metab 85 (2000) 4908-4911
125. Tanaka M., Hayashida Y., Nakao N., Nakai N., and Nakashima K. Testis-specific and developmentally induced expression of a ghrelin gene-derived transcript that encodes a novel polypeptide in the mouse. Biochim Biophys Acta 1522 (2001) 62-65
126. + channel: a pas de deux. Diabetes 53 (2004) S113-S122
127. Tena-Sempere M., Barreiro M.L., Gonzalez L.C., Gaytan F., Zhang F.P., Caminos J.E., et al. Novel expression and functional role of ghrelin in rat testis. Endocrinology 143 (2002) 717-725
128. Thompson N.M., Gill D.A., Davies R., Loveridge N., Houston P.A., Robinson I.C., et al. Ghrelin and des-octanoyl ghrelin promote adipogenesis directly in vivo by a mechanism independent of the type 1a growth hormone secretagogue receptor. Endocrinology 145 (2004) 234-242
129. Toshinai K., Mondal M.S., Nakazato M., Date Y., Murakami N., Kojima M., et al. Upregulation of Ghrelin expression in the stomach upon fasting, insulin-induced hypoglycemia, and leptin administration. Biochem Biophys Res Commun 281 (2001) 1220-1225
130. Tschop M., Smiley D.L., and Heiman M.L. Ghrelin induces adiposity in rodents. Nature 407 (2000) 908-913
131. Tschop M., Weyer C., Tataranni P.A., Devanarayan V., Ravussin E., and Heiman M.L. Circulating ghrelin levels are decreased in human obesity. Diabetes 50 (2001) 707-709
132. Urano Y., Sakurai T., Ueda H., Ogasawara J., Sakurai T., Takei M., et al. Desensitization of the inhibitory effect of norepinephrine on insulin secretion from pancreatic islets of exercise-trained rats. Metabolism 53 (2004) 1424-1432
133. Volante M., Allia E., Gugliotta P., Funaro A., Broglio F., Deghenghi R., et al. Expression of ghrelin and of the GH secretagogue receptor by pancreatic islet cells and related endocrine tumors. J Clin Endocrinol Metab 87 (2002) 1300-1308
134. Volante M., Fulcheri E., Allia E., Cerrato M., Pucci A., and Papotti M. Ghrelin expression in fetal, infant, and adult human lung. J Histochem Cytochem 50 (2002) 1013-1021
135. Wang X., Liang L., and Du L. The effects of intrauterine undernutrition on pancreas ghrelin and insulin expression in neonate rats. J Endocrinol 194 (2007) 121-129
136. Wasmeier C., and Hutton J.C. Molecular cloning of phogrin, a protein-tyrosine phosphatase homologue localized to insulin secretory granule membranes. J Biol Chem 271 (1996) 18161-18170
137. Wierup N., and Sundler F. Ultrastructure of islet ghrelin cells in the human fetus. Cell Tissue Res 319 (2005) 423-428
138. Wierup N., Svensson H., Mulder H., and Sundler F. The ghrelin cell: a novel developmentally regulated islet cell in the human pancreas. Regul Pept 107 (2002) 63-69
139. Wierup N., Yang S., McEvilly R.J., Mulder H., and Sundler F. Ghrelin is expressed in a novel endocrine cell type in developing rat islets and inhibits insulin secretion from INS-1 (832/13) cells. J Histochem Cytochem 52 (2004) 301-310
140. Wollheim C.B., and Sharp G.W.G. Regulation of insulin release by calcium. Physiol Rev 61 (1981) 914-973
141. Wortley K.E., Anderson K.D., Garcia K., Murray J.D., Malinova L., Liu R., et al. Genetic deletion of ghrelin does not decrease food intake but influences metabolic fuel preference. Proc Natl Acad Sci U S A 101 (2004) 8227-8232
142. Wortley K.E., del Rincon J.P., Murray J.D., Garcia K., Iida K., Thorner M.O., et al. Absence of ghrelin protects against early-onset obesity. J Clin Invest 115 (2005) 3573-3578
143. Wren A.M., Seal L.J., Cohen M.A., Brynes A.E., Frost G.S., Murphy K.G., et al. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 86 (2001) 5992-5995
144. Wren A.M., Small C.J., Abbott C.R., Dhillo W.S., Seal L.J., Cohen M.A., et al. Ghrelin causes hyperphagia and obesity in rats. Diabetes 50 (2001) 2540-2547
145. Yan L., Figueroa D.J., Austin C.P., Liu Y., Bugianesi R.M., Slaughter R.S., et al. Expression of voltage-gated potassium channels in human and rhesus pancreatic islets. Diabetes 53 (2004) 597-607
146. Zhang Y., Proenca R., Maffei M., Barone M., Leopold L., and Friedman J.M. Positional cloning of the mouse obese gene and its human homologue. Nature 372 (1994) 425-432
147. Zhang C.Y., Baffy G., Perret P., Krauss S., Peroni O., Grujic D., et al. Uncoupling protein-2 negatively regulates insulin secretion and is a major link between obesity, β cell dysfunction, and type 2 diabetes. Cell 105 (2001) 745-755
148. Zhang J.V., Ren P.G., Avsian-Kretchmer O., Luo C.W., Rauch R., Klein C., et al. Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake. Science 310 (2005) 996-999